URL details: type-2-diabetes-management.net/media-centre/press-releases/2022/imfinzi-and-tremelimumab-with-chemotherapy-demonstrated-sustained-survival-benefit-in-metastatic-non-small-cell-lung-cancer.html

home > domains > type-2-diabetes-management.net > type-2-diabetes-management.net/media-centre/press-releases/2022/imfinzi-and-tremelimumab-with-chemotherapy-demonstrated-sustained-survival-benefit-in-metastatic-non-small-cell-lung-cancer.html

URL title: AstraZeneca - Research-Based BioPharmaceutical Company
URL description: AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
URL last crawled: 2022-09-15
URL speed: 0.402 MB/s, downloaded in 0.100 seconds

open external url

We found no external links pointing to this url.